Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

FORM 10-Q

 

(Mark One)

 

 

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2003

 

 

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM             TO             .

 

 

 

Commission file number 1-9278

 

CARLISLE COMPANIES INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

31-1168055

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

13925 Ballantyne Corporate Place, Suite 400, Charlotte, NC 28277

 

704-501-1100

(Address of principal executive office, including zip code)

 

(Telephone Number)

 

 

Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  ý  No  o

 

Shares of common stock outstanding at August 1, 2003: 30,675,640

 

 



 

Carlisle Companies Incorporated and Subsidiaries

Condensed Consolidated Statements of Earnings and Comprehensive Income

Three and Six Months ended June 30, 2003 and 2002

(dollars in thousands, except per share amounts)

(unaudited)

 

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

(Restated*)

 

Net sales

 

$

554,413

 

$

552,283

 

$

1,030,101

 

$

1,007,383

 

 

 

 

 

 

 

 

 

 

 

Cost and expenses:

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

453,353

 

451,011

 

838,872

 

822,731

 

Selling and administrative expenses

 

53,686

 

53,577

 

105,627

 

105,421

 

Research and development expenses

 

4,819

 

5,290

 

9,624

 

10,449

 

Other (income) and expense, net

 

(3,631

)

536

 

(543

)

2,173

 

Earnings before interest and income taxes and cumulative effect of change in accounting principle

 

46,186

 

41,869

 

76,521

 

66,609

 

Interest expense, net

 

3,239

 

4,096

 

7,869

 

9,244

 

Earnings before income taxes and cumulative effect of change in accounting principle

 

42,947

 

37,773

 

68,652

 

57,365

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

14,387

 

13,032

 

22,998

 

19,791

 

Income before cumulative effect of change in accounting principle

 

28,560

 

24,741

 

45,654

 

37,574

 

 

 

 

 

 

 

 

 

 

 

Cumulative effect of change in accounting principle net of taxes of $12,072

 

 

 

 

(43,753

)

Net income (loss)

 

$

28,560

 

$

24,741

 

$

45,654

 

$

(6,179

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

Foreign currency translation, net of tax

 

1,640

 

6,869

 

3,212

 

5,496

 

Gain (loss) on hedging activities, net of tax

 

254

 

(825

)

508

 

(574

)

Other comprehensive income

 

1,894

 

6,044

 

3,720

 

4,922

 

Comprehensive income (loss)

 

$

30,454

 

$

30,785

 

$

49,374

 

$

(1,257

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share - basic

 

 

 

 

 

 

 

 

 

Income before cumulative effect of change in accounting principle

 

$

0.93

 

$

0.81

 

$

1.49

 

$

1.24

 

Cumulative effect of change in accounting principle

 

 

 

 

(1.44

)

Net income (loss)

 

$

0.93

 

$

0.81

 

$

1.49

 

$

(0.20

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share - diluted

 

 

 

 

 

 

 

 

 

Income before cumulative effect of change in accounting principle

 

$

0.93

 

$

0.81

 

$

1.49

 

$

1.23

 

Cumulative effect of change in accounting principle

 

 

 

 

(1.43

)

Net income (loss)

 

$

0.93

 

$

0.81

 

$

1.49

 

$

(0.20

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

Basic

 

30,647

 

30,380

 

30,628

 

30,337

 

Effect of dilutive stock options

 

115

 

141

 

104

 

146

 

Diluted

 

30,762